No takes yet. Share an insight, caveat, or question.
Delphi consensus study reports expert agreement on biomarker access and disease-modifying therapy pathways in dementia care, highlighting framework updates for clinical practice.
Marra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: